Loading...

Fund Overview

Fund Size

Fund Size

₹2,382 Cr

Expense Ratio

Expense Ratio

0.46%

ISIN

ISIN

INF174KA1TG9

Minimum SIP

Minimum SIP

₹100

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

28 Oct 2024

About this fund

This fund has been in existence for 3 months and 1 days, having been launched on 28-Oct-24.
As of 28-Jan-25, it has a Net Asset Value (NAV) of ₹9.36, Assets Under Management (AUM) of 2381.91 Crores, and an expense ratio of 0.46%.
  • Kotak MNC Fund Direct Growth has given a CAGR return of -6.39% since inception.
  • The fund's asset allocation comprises around 86.98% in equities, 0.00% in debts, and 13.02% in cash & cash equivalents.
  • You can start investing in Kotak MNC Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

-6.39%

(Cat Avg.)

Portfolio Summaryas of 31st December 2024

Equity2,071.67 Cr86.98%
Others310.24 Cr13.02%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Triparty RepoCash - Repurchase Agreement314.3 Cr13.20%
Hindustan Unilever LtdEquity171.65 Cr7.21%
Maruti Suzuki India LtdEquity168.31 Cr7.07%
Britannia Industries LtdEquity122.97 Cr5.16%
Oracle Financial Services Software LtdEquity91.44 Cr3.84%
United Spirits LtdEquity90.08 Cr3.78%
Siemens LtdEquity80.79 Cr3.39%
Nestle India LtdEquity74.3 Cr3.12%
Swiggy LtdEquity72.69 Cr3.05%
Infosys LtdEquity63.81 Cr2.68%
Tech Mahindra LtdEquity63.13 Cr2.65%
Tata Chemicals LtdEquity57.19 Cr2.40%
Sun Pharmaceuticals Industries LtdEquity56.02 Cr2.35%
Bharti Airtel LtdEquity53.76 Cr2.26%
ABB India LtdEquity50.94 Cr2.14%
Glenmark Pharmaceuticals LtdEquity46.17 Cr1.94%
Marksans Pharma LtdEquity45.88 Cr1.93%
Nippon Life India Asset Management Ltd Ordinary SharesEquity44.78 Cr1.88%
GE Vernova T&D India LtdEquity44.18 Cr1.85%
J.B. Chemicals & Pharmaceuticals LtdEquity43.84 Cr1.84%
Mphasis LtdEquity40.83 Cr1.71%
Colgate-Palmolive (India) LtdEquity40.42 Cr1.70%
CRISIL LtdEquity40.38 Cr1.70%
Schaeffler India LtdEquity40.16 Cr1.69%
Ashok Leyland LtdEquity40.13 Cr1.68%
Jubilant Pharmova LtdEquity40.01 Cr1.68%
Aster DM Healthcare Ltd Ordinary SharesEquity39.57 Cr1.66%
Timken India LtdEquity38.86 Cr1.63%
Cummins India LtdEquity36.6 Cr1.54%
Fortis Healthcare LtdEquity36.35 Cr1.53%
Bosch LtdEquity31.76 Cr1.33%
Azad Engineering LtdEquity31.5 Cr1.32%
Tega Industries LtdEquity29.2 Cr1.23%
MTAR Technologies LtdEquity28.99 Cr1.22%
Orchid Pharma LtdEquity24 Cr1.01%
Ami Organics LtdEquity21.42 Cr0.90%
Samvardhana Motherson International LtdEquity20.21 Cr0.85%
KSB LtdEquity18.67 Cr0.78%
Sona BLW Precision Forgings LtdEquity18.14 Cr0.76%
Sai Life Sciences LtdEquity12.53 Cr0.53%
Net Current Assets/(Liabilities)Cash-4.06 Cr0.17%

Allocation By Market Cap (Equity)

Large Cap Stocks

43.99%

Mid Cap Stocks

19.96%

Small Cap Stocks

19.45%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Consumer Defensive499.42 Cr20.97%
Industrials399.86 Cr16.79%
Consumer Cyclical351.26 Cr14.75%
Healthcare344.37 Cr14.46%
Technology259.21 Cr10.88%
Financial Services85.17 Cr3.58%
Basic Materials78.61 Cr3.30%
Communication Services53.76 Cr2.26%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

--

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

--

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

--

Higher the better

Fund Managers

HU

Harsha Upadhyaya

Since October 2024

Abhishek Bisen

Abhishek Bisen

Since October 2024

DT

Dhananjay Tikariha

Since October 2024

Additional Scheme Detailsas of 31st December 2024

ISIN
INF174KA1TG9
Expense Ratio
0.46%
Exit Load
No Charges
Fund Size
₹2,382 Cr
Age
3 months
Lumpsum Minimum
₹100
Fund Status
Open Ended Investment Company
Benchmark
Nifty MNC TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Equity - Other Funds

Fund nameExpense RatioExit LoadFund size
1Y
SBI Equity Minimum Variance Fund Direct Growth

Very High Risk

0.4%0.0%₹212.14 Cr5.4%
SBI Equity Minimum Variance Fund Regular Growth

Very High Risk

0.8%0.0%₹212.14 Cr5.1%
Bandhan Transportation and Logistics Fund Direct Growth

Very High Risk

0.9%0.0%₹534.00 Cr11.8%
Bandhan Transportation and Logistics Fund Regular Growth

Very High Risk

2.4%0.0%₹534.00 Cr10.1%
ICICI Prudential Transportation and Logistics Fund Direct Growth

Very High Risk

0.8%1.0%₹3101.23 Cr19.2%
ICICI Prudential Transportation and Logistics Fund Regular Growth

Very High Risk

1.9%1.0%₹3101.23 Cr17.8%
HDFC NIFTY200 Momentum 30 ETF

Very High Risk

0.3%-₹11.35 Cr63.0%
HDFC NIFTY100 Low Volatility 30 ETF

Very High Risk

0.3%-₹5.95 Cr34.7%
ICICI Prudential Nifty 200 Momentum 30 ETF

Very High Risk

0.3%-₹414.11 Cr1.8%
DSP Nifty Midcap 150 Quality 50 ETF

Very High Risk

0.3%-₹98.49 Cr8.8%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Kotak MNC Fund Direct Growth, as of 28-Jan-2025, is ₹9.36.
The fund's allocation of assets is distributed as 86.98% in equities, 0.00% in bonds, and 13.02% in cash and cash equivalents.
The fund managers responsible for Kotak MNC Fund Direct Growth are:-
  1. Harsha Upadhyaya
  2. Abhishek Bisen
  3. Dhananjay Tikariha

Fund Overview

Fund Size

Fund Size

₹2,382 Cr

Expense Ratio

Expense Ratio

0.46%

ISIN

ISIN

INF174KA1TG9

Minimum SIP

Minimum SIP

₹100

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

28 Oct 2024

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

About this fund

This fund has been in existence for 3 months and 1 days, having been launched on 28-Oct-24.
As of 28-Jan-25, it has a Net Asset Value (NAV) of ₹9.36, Assets Under Management (AUM) of 2381.91 Crores, and an expense ratio of 0.46%.
  • Kotak MNC Fund Direct Growth has given a CAGR return of -6.39% since inception.
  • The fund's asset allocation comprises around 86.98% in equities, 0.00% in debts, and 13.02% in cash & cash equivalents.
  • You can start investing in Kotak MNC Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

-6.39%

(Cat Avg.)

Portfolio Summaryas of 31st December 2024

Equity2,071.67 Cr86.98%
Others310.24 Cr13.02%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Triparty RepoCash - Repurchase Agreement314.3 Cr13.20%
Hindustan Unilever LtdEquity171.65 Cr7.21%
Maruti Suzuki India LtdEquity168.31 Cr7.07%
Britannia Industries LtdEquity122.97 Cr5.16%
Oracle Financial Services Software LtdEquity91.44 Cr3.84%
United Spirits LtdEquity90.08 Cr3.78%
Siemens LtdEquity80.79 Cr3.39%
Nestle India LtdEquity74.3 Cr3.12%
Swiggy LtdEquity72.69 Cr3.05%
Infosys LtdEquity63.81 Cr2.68%
Tech Mahindra LtdEquity63.13 Cr2.65%
Tata Chemicals LtdEquity57.19 Cr2.40%
Sun Pharmaceuticals Industries LtdEquity56.02 Cr2.35%
Bharti Airtel LtdEquity53.76 Cr2.26%
ABB India LtdEquity50.94 Cr2.14%
Glenmark Pharmaceuticals LtdEquity46.17 Cr1.94%
Marksans Pharma LtdEquity45.88 Cr1.93%
Nippon Life India Asset Management Ltd Ordinary SharesEquity44.78 Cr1.88%
GE Vernova T&D India LtdEquity44.18 Cr1.85%
J.B. Chemicals & Pharmaceuticals LtdEquity43.84 Cr1.84%
Mphasis LtdEquity40.83 Cr1.71%
Colgate-Palmolive (India) LtdEquity40.42 Cr1.70%
CRISIL LtdEquity40.38 Cr1.70%
Schaeffler India LtdEquity40.16 Cr1.69%
Ashok Leyland LtdEquity40.13 Cr1.68%
Jubilant Pharmova LtdEquity40.01 Cr1.68%
Aster DM Healthcare Ltd Ordinary SharesEquity39.57 Cr1.66%
Timken India LtdEquity38.86 Cr1.63%
Cummins India LtdEquity36.6 Cr1.54%
Fortis Healthcare LtdEquity36.35 Cr1.53%
Bosch LtdEquity31.76 Cr1.33%
Azad Engineering LtdEquity31.5 Cr1.32%
Tega Industries LtdEquity29.2 Cr1.23%
MTAR Technologies LtdEquity28.99 Cr1.22%
Orchid Pharma LtdEquity24 Cr1.01%
Ami Organics LtdEquity21.42 Cr0.90%
Samvardhana Motherson International LtdEquity20.21 Cr0.85%
KSB LtdEquity18.67 Cr0.78%
Sona BLW Precision Forgings LtdEquity18.14 Cr0.76%
Sai Life Sciences LtdEquity12.53 Cr0.53%
Net Current Assets/(Liabilities)Cash-4.06 Cr0.17%

Allocation By Market Cap (Equity)

Large Cap Stocks

43.99%

Mid Cap Stocks

19.96%

Small Cap Stocks

19.45%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Consumer Defensive499.42 Cr20.97%
Industrials399.86 Cr16.79%
Consumer Cyclical351.26 Cr14.75%
Healthcare344.37 Cr14.46%
Technology259.21 Cr10.88%
Financial Services85.17 Cr3.58%
Basic Materials78.61 Cr3.30%
Communication Services53.76 Cr2.26%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

--

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

--

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

--

Higher the better

Fund Managers

HU

Harsha Upadhyaya

Since October 2024

Abhishek Bisen

Abhishek Bisen

Since October 2024

DT

Dhananjay Tikariha

Since October 2024

Additional Scheme Detailsas of 31st December 2024

ISIN
INF174KA1TG9
Expense Ratio
0.46%
Exit Load
No Charges
Fund Size
₹2,382 Cr
Age
3 months
Lumpsum Minimum
₹100
Fund Status
Open Ended Investment Company
Benchmark
Nifty MNC TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Equity - Other Funds

Fund nameExpense RatioExit LoadFund size
1Y
SBI Equity Minimum Variance Fund Direct Growth

Very High Risk

0.4%0.0%₹212.14 Cr5.4%
SBI Equity Minimum Variance Fund Regular Growth

Very High Risk

0.8%0.0%₹212.14 Cr5.1%
Bandhan Transportation and Logistics Fund Direct Growth

Very High Risk

0.9%0.0%₹534.00 Cr11.8%
Bandhan Transportation and Logistics Fund Regular Growth

Very High Risk

2.4%0.0%₹534.00 Cr10.1%
ICICI Prudential Transportation and Logistics Fund Direct Growth

Very High Risk

0.8%1.0%₹3101.23 Cr19.2%
ICICI Prudential Transportation and Logistics Fund Regular Growth

Very High Risk

1.9%1.0%₹3101.23 Cr17.8%
HDFC NIFTY200 Momentum 30 ETF

Very High Risk

0.3%-₹11.35 Cr63.0%
HDFC NIFTY100 Low Volatility 30 ETF

Very High Risk

0.3%-₹5.95 Cr34.7%
ICICI Prudential Nifty 200 Momentum 30 ETF

Very High Risk

0.3%-₹414.11 Cr1.8%
DSP Nifty Midcap 150 Quality 50 ETF

Very High Risk

0.3%-₹98.49 Cr8.8%

Still got questions?
We're here to help.

The NAV of Kotak MNC Fund Direct Growth, as of 28-Jan-2025, is ₹9.36.
The fund's allocation of assets is distributed as 86.98% in equities, 0.00% in bonds, and 13.02% in cash and cash equivalents.
The fund managers responsible for Kotak MNC Fund Direct Growth are:-
  1. Harsha Upadhyaya
  2. Abhishek Bisen
  3. Dhananjay Tikariha
close

Get your portfolio reviewed by experts